BioCentury
ARTICLE | Clinical News

TeaRxaban: Phase II started

January 27, 2014 8:00 AM UTC

TeaRx began a Russian Phase II trial to compare TeaRxaban vs. enoxaparin in patients undergoing knee replacement surgery. The company has exclusive rights to develop and commercialize the compound in ...